|
|
|
Volumn 40, Issue 1039, 1998, Pages 106-108
|
|
Trastuzumab and capecitabine for metastatic breast cancer
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
CAPECITABINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
MONOCLONAL ANTIBODY;
PACLITAXEL;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ADVERSE DRUG REACTION;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CLINICAL TRIAL;
DIARRHEA;
DRUG ABSORPTION;
DRUG COST;
DRUG HALF LIFE;
DRUG RESISTANCE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NAUSEA;
ONCOGENE NEU;
ORAL DRUG ADMINISTRATION;
SHORT SURVEY;
STOMATITIS;
ADMINISTRATION, ORAL;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
COSTS AND COST ANALYSIS;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
|
|
EID: 0032491556
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (5)
|
|
References (6)
|
